ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,126 | -35.0% | 54,518 | -5.1% | 0.00% | – |
| Q2 2023 | $169,383 | -75.9% | 57,418 | -79.5% | 0.00% | – |
| Q1 2023 | $701,598 | -19.4% | 280,639 | +2.2% | 0.00% | – |
| Q4 2022 | $870,647 | +6.2% | 274,652 | -0.6% | 0.00% | – |
| Q3 2022 | $820,000 | -4.1% | 276,293 | -1.3% | 0.00% | – |
| Q2 2022 | $855,000 | -77.1% | 280,044 | +1.3% | 0.00% | -100.0% |
| Q1 2022 | $3,731,000 | -0.8% | 276,372 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $3,761,000 | +38.7% | 288,687 | -0.1% | 0.00% | – |
| Q3 2021 | $2,711,000 | +162.7% | 289,072 | +186.8% | 0.00% | – |
| Q2 2021 | $1,032,000 | -63.2% | 100,785 | -33.9% | 0.00% | -100.0% |
| Q1 2021 | $2,808,000 | -43.6% | 152,585 | +5.0% | 0.00% | 0.0% |
| Q4 2020 | $4,977,000 | – | 145,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |